speb/financial-data huggingface dataset:
REGENCERAM.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 0.00
REGENCERAM.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 43099000.00
REGENCERAM.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 480000.00
REGENCERAM.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 480000.00
REGENCERAM.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -37500000.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: -820444000.00
REGENCERAM.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 2000000.00
REGENCERAM.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 38000.00
REGENCERAM.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 11463000.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Share Issued: 26441586.00
REGENCERAM.NS income_statement (annual, 2022-03-31) — Special Income Charges: 376243000.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: -368946000.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: -368946000.00
REGENCERAM.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
REGENCERAM.NS income_statement (annual, 2022-03-31) — Tax Provision: 0.00
REGENCERAM.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 2735000.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Total Assets: 711451000.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 204610000.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Total Debt: 573556000.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: -368946000.00
REGENCERAM.NS income_statement (annual, 2022-03-31) — Total Expenses: 56668000.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 1080397000.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 244567000.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 588086000.00
REGENCERAM.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 28000.00
REGENCERAM.NS income_statement (annual, 2022-03-31) — Total Unusual Items: 378234000.00
REGENCERAM.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 378234000.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Trading Securities: 0.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Work In Process: 0.00
REGENCERAM.NS balance_sheet (annual, 2022-03-31) — Working Capital: -25427000.00
REGENCERAM.NS income_statement (annual, 2022-03-31) — Write Off: 425000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — +Operating Expense: 31605000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — +Total Revenue: 408000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 247507000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 79743000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -1886030000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 32961000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -2868000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 26441586.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Basic EPS: -5.92
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 1207000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 183683000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 264416000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 3261000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 3261000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 3261000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 1699000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 121568000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Change In Payable: 2401000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 26482000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 150451000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 2054000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Common Stock: 264416000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: -525374000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 0.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 365000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Current Assets: 315732000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Current Debt: 0.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 0.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 589264000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Depreciation: 42830000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 42830000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 42830000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 42830000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 26441586.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Diluted EPS: -5.92
REGENCERAM.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -156428000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — EBIT: -156428000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — EBITDA: -113598000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — End Cash Position: 3261000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 137302000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 2020000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 133048000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -1707000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -25000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 9441000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 0.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 82611000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 2085248000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Gross Profit: 43000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Held To Maturity Securities: 42000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Interest Expense: 0.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 0.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Interest Income: 2489000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 2489000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: 0.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 2489000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Inventory: 0.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 50202000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -133014000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 137344000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 2020000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 6336000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 575576000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 575576000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 2020000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: 0.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 14530000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 1895229000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Net Debt: 572315000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Net Income: -156428000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -156428000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -156428000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -156428000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -156428000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -156428000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -156428000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Net Interest Income: 2424000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -133806000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 2020000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 2020000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 2424000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -1697000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Net PPE: 199218000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: 25000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: -525374000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 14530000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 1705000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 14101000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Normalized Income: -28729000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 133048000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Operating Income: -31562000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Operating Revenue: 408000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 26441586.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 3000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 200352000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: -789790000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 94829000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -2000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 409000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: -24533000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Other Payable: 12691000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Other Properties: 199216000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 41437000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 42574000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Other Special Charges: 126309000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Payables: 260198000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 97336000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 188294000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Pretax Income: -156428000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -29016000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -133806000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 365000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 42830000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 565000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 565000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: 0.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: -976872000.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 0.00
REGENCERAM.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 25000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 80000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 9521000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Share Issued: 26441586.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Special Income Charges: -129382000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: -525374000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: -525374000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Tax Provision: 0.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 2994000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Total Assets: 653996000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 50202000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Total Debt: 575576000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: -525374000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Total Expenses: 31970000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 1179370000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 338265000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 590106000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 65000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -127699000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -127699000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Trading Securities: 137204000.00
REGENCERAM.NS balance_sheet (annual, 2023-03-31) — Working Capital: -273532000.00
REGENCERAM.NS income_statement (annual, 2023-03-31) — Write Off: 3073000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — +Operating Expense: 110073000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — +Total Revenue: 21588000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 262057000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 91727000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1713906000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 32961000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -2868000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 72000000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 26441586.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Basic EPS: -3.71
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 3261000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 183683000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 264416000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 1952000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 2261000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 1951000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 16436000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Change In Payable: 14550000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -38034000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -7048000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -1309000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Common Stock: 264416000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: -623442000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 79429000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 19216000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Current Assets: 352455000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 620250000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Depreciation: 41595000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 41595000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 41595000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 41595000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 26441586.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Diluted EPS: -3.71
REGENCERAM.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -98068000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — EBIT: -98068000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — EBITDA: -56473000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — End Cash Position: 1952000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 18840000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 98381000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -77116000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -13355000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 13741000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 5100000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 94595000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 1949061000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Gross Profit: 2372000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Held To Maturity Securities: 42000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Interest Expense: 0.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 0.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Interest Income: 240000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 240000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 240000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Inventory: 0.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 50515000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -22574000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 90882000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 98381000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 6336000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 673957000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 673957000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 98381000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 14530000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 1679613000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Net Debt: 672005000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Net Income: -98068000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -98068000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -98068000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -98068000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -98068000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -98068000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -98068000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Net Interest Income: 203000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 125648000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 98381000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 98381000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 203000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -160105000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Net PPE: 235155000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: 11643000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: -628542000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 14530000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 1705000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: -65528000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Normalized Income: -107123000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: -77116000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Operating Income: -107701000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Operating Revenue: 21588000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 26441586.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 1000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 199094000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: -887858000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 5100000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -240000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -3000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: -1000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 375000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 8816000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Other Payable: 21826000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 44378000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 309000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Other Special Charges: -1869000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Payables: 283883000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 99420000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 193001000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Pretax Income: -98068000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -72000000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 19216000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 41595000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 3211000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 3211000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: -1074940000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 125648000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 11643000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 8677000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 22418000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Share Issued: 26441586.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Special Income Charges: 1869000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: -623442000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: -628542000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Tax Provision: 0.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 21087000.00
REGENCERAM.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: 0.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Total Assets: 685295000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 50515000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Total Debt: 673957000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: -623442000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Total Expenses: 129289000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 1308737000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 332839000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 688487000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 37000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 9055000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 9055000.00
REGENCERAM.NS balance_sheet (annual, 2024-03-31) — Working Capital: -267795000.00
REGENCERAM.NS income_statement (annual, 2024-03-31) — Write Off: 0.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 269353000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 94311000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 74276000.00
REGENCERAM.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 26462887.00
REGENCERAM.NS income_statement (quarterly, 2024-09-30) — Basic EPS: -0.97
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 264416000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 4448000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 70036000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 264416000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: -677223000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 401800000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 26542000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 26542000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 649883000.00
REGENCERAM.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 26462887.00
REGENCERAM.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.97
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 19016000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 73376000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 74276000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 724057000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 724057000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 14530000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 746151000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 217550000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: -677223000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 26441586.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 214502000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 231243000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: -941639000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 17620000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 65588000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Payables: 269353000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 26441586.00
REGENCERAM.NS income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: -677223000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: -677223000.00
REGENCERAM.NS income_statement (quarterly, 2024-09-30) — Tax Provision: 0.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 3935000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 711247000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 46834000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 750599000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: -677223000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 1388470000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 309446000.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 738587000.00
REGENCERAM.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
REGENCERAM.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
REGENCERAM.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: -248083000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 30494000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 39608000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 26442759.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Basic EPS: -1.45
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 50496000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 10016000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 10016000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 26442759.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: -1.45
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -38342000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — EBIT: -36899000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — EBITDA: -26883000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Gross Profit: -10888000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 1443000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 1443000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Net Income: -38342000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -38342000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -38342000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -38342000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -38342000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -38342000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -1443000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -1443000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -26883000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Normalized Income: -38342000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Operating Income: -41382000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 39608000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 4484000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 13065000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Pretax Income: -38342000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 50496000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 10016000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 0.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 80990000.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
REGENCERAM.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — +Operating Expense: 221255000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 91096000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — +Total Revenue: 131470000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 70199000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 431560000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 431560000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 126760000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 126760000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1478189000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1478189000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 32961000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 32961000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -2868000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -2868000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Amortization: 1104000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 72000000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 72000000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 26471765.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 26471594.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Basic EPS: 0.85
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 4.33
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 1952000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 183683000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 183683000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 264416000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 264416000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 6912000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 6912000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 6912000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 6912000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 6912000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 6912000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 77131000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Change In Payable: 196255000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -351629000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -78243000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 4960000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Common Stock: 264416000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 264416000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: -600942000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -600942000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 99153000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 99153000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 81911000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 49615000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Current Assets: 697682000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 697682000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Current Debt: 67927000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 67927000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 67927000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 67927000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 866885000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 866885000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Depreciation: 40534000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 40534000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 40534000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 9804000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 40534000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 9804000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 26471765.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 26471594.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Diluted EPS: 0.85
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 4.33
REGENCERAM.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 22501000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 114622000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — EBIT: -45486000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — EBIT: 44963000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — EBITDA: -4952000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — EBITDA: 54767000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — End Cash Position: 6911000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 443000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 443000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 31300000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -134599000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -2955000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 18602000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 8084000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 8084000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 129627000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 129627000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 1683835000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1683835000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Gross Profit: 49559000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 20584000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Held To Maturity Securities: 42000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 42000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Interest Expense: 3295000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 1623000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 3295000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1623000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Interest Income: 101046000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 101046000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 101046000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Inventory: 241249000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 241249000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 172242000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 172242000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: 108259000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 72485000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 72485000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 31300000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 6336000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 6336000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 705257000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 705257000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 705257000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 705257000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 31300000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 14530000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 14530000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 1394663000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1394663000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Net Debt: 766272000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 766272000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Net Income: 22501000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Net Income: 114622000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 22501000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 114622000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 22501000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 114622000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 22501000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 114622000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 22501000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 114622000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -48781000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 22501000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 114622000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Net Interest Income: -3295000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -1623000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 18314000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 31300000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 31300000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -3295000.00
REGENCERAM.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1623000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -24572000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Net PPE: 205646000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 205646000.00
REGENCERAM.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: 13471000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: -609026000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -609026000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 14530000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 14530000.00
REGENCERAM.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 1837000.00
REGENCERAM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 1837000.00
REGENCERAM.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: -4952000.00